News | Acute pain

Feature

Changes in migraine treatment: how new classes of drugs can provide additional options for patients and prescribers

This episode of The PJ Pod looks at recent changes to National Institute for Health and Care Excellence guidance on the treatment of acute and chronic migraine and what pharmacists should expect from the new class of gepant drugs.…

Published: 2 August 2024

News

NSAID prescribing in high-risk groups is a major source of avoidable harm, study finds

The study estimated that the practice could have caused more than 6,000 lost years of good health across England over a ten-year period.…

Published: 26 July 2024

News

Pregabalin prescribing increases by almost 25% since restrictions imposed

Exclusive: Almost 670,000 patients in England were prescribed pregabalin when it was first reclassified in 2018/2019, compared with more than 820,000 patients in 2023/2024.…

Published: 10 June 2024

News

NICE guidance ‘addresses the high unmet need’ for treatment of acute migraine

The National Institute for Health and Care Excellence has recommended rimegepant for acute migraine — the first available oral treatment for the condition.…

Published: 14 September 2023

Opinion

‘Painkillers don’t exist’: how our campaign helped to reduce opioid prescribing

Educating patients on the risks of analgesics and non-pharmacological alternatives has helped North East and North Cumbria Integrated Care Board reduce opioid prescribing.…

Published: 3 July 2023

News

Medicated wafer to be approved for the treatment of frequent migraines on the NHS

Rimegepant will be available on the NHS for patients who have tried at least 3 other preventative therapies, and have at least 4 and fewer than 15 migraine attacks per month.…

Published: 1 June 2023

News

No antidepressant found to be effective and safe for chronic pain, evidence review shows

The review of 176 studies included patients with a range of chronic pain conditions, including fibromyalgia, neuropathic pain and musculoskeletal pain.…

Published: 15 May 2023

News

Give prescribers access to non-drug alternatives to antidepressants and opioids, says NHS

In a new framework, NHS England recommends alternative treatment options, such as psychotherapy, health coaching and pain or sleep clinics, are commissioned locally.…

Published: 2 March 2023

News

Alternative to injections for people with severe migraines approved for use on NHS

Eptinezumab, a calcitonin gene-related peptide inhibitor, will be available on the NHS for people with episodic and chronic migraines who meet certain conditions.…

Published: 27 January 2023

News

Wales is first UK nation to publish guidance on analgesic stewardship

The guidance aims to improve patient outcomes, reduce analgesic-related harm and ensure cost-effective use of analgesics.…

Published: 17 November 2022